Literature DB >> 15047128

Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren's contracture.

Jeffrey C Howard1, Vincenzo M Varallo, Douglas C Ross, Kenneth J Faber, James H Roth, Shannon Seney, Bing Siang Gan.   

Abstract

BACKGROUND: Dupuytren's contracture or disease (DD) affects hand function by causing irreversible contraction of the palmar fascia. Histological analysis has shown that DD and wound granulation tissue share many cellular and biochemical characteristics, suggesting that DD may be an exaggerated wound-healing response. The goal of the present study was to examine the possible involvement of two important wound-healing-associated proteins-heat shock protein 47 (Hsp47), fibronectin (Fn), and its oncofetal isoforms-in DD, using clinical tissue samples and primary cell cultures.
MATERIALS AND METHODS: We examined the expression of Hsp47, Fn, and an oncofetal isoform of fibronectin (IIICS) in both normal and disease-matched surgical specimens and primary cell cultures using Western blot analysis, and immunocytochemistry (ICC).
RESULTS: Our results indicate that Hsp47 and total fibronectin is elevated in DD lesional tissue. In addition, Western and ICC analysis of patient-matched (normal and disease) primary cultures show significantly elevated levels of oncofetal fibronectin (IIICS spliced variant) within disease primary cell cultures.
CONCLUSIONS: The high levels of expression of Hsp47 and adult and oncofetal fibronectin in DD suggests that cell-mediated alterations in the extracellular environment may play an important role in the disease process. Furthermore, the involvement of these wound healing-associated proteins in DD supports the notion that this disease may be an exaggerated form of wound healing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047128     DOI: 10.1016/j.jss.2004.01.013

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  20 in total

1.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

2.  WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.

Authors:  Justin Crawford; Christina Raykha; Daevina Charles; Bing Siang Gan; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2015-06-30       Impact factor: 5.782

Review 3.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

5.  Expression of VEGF, its receptors, and HIF-1α in Dupuytren's disease.

Authors:  Lukas A Holzer; Andrej Cör; Gerhard Pfandlsteiner; Gerold Holzer
Journal:  Acta Orthop       Date:  2013-07-03       Impact factor: 3.717

6.  Heat shock proteins modulate keloid formation.

Authors:  Serhat Totan; Anthony Echo; Eser Yuksel
Journal:  Eplasty       Date:  2011-04-29

7.  Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.

Authors:  Latha Satish; Phillip H Gallo; Mark E Baratz; Sandra Johnson; Sandeep Kathju
Journal:  BMC Musculoskelet Disord       Date:  2011-05-25       Impact factor: 2.362

8.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

9.  Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.

Authors:  Latha Satish; William A LaFramboise; Sandra Johnson; Linda Vi; Anna Njarlangattil; Christina Raykha; John Michael Krill-Burger; Phillip H Gallo; David B O'Gorman; Bing Siang Gan; Mark E Baratz; Garth D Ehrlich; Sandeep Kathju
Journal:  BMC Med Genomics       Date:  2012-05-04       Impact factor: 3.063

10.  Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Authors:  Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman
Journal:  BMC Musculoskelet Disord       Date:  2009-06-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.